0001035267-26-000032
SEC filingQ1 delivered accelerating revenue growth and exceptional margin expansion, driving record operating income through procedure-driven recurring revenue strength and scalable business model leverage.
Operating income more than doubled to $855M, achieving a 30.9% margin through operating leverage as procedure-driven revenue growth outpaced SG&A and R&D expenses. The increase in system placements reflects continued customer demand for additional capacity tied to procedure expansion and heightened interest in the da Vinci 5 system, including trade-ins of fourth-generation systems. This dynamic validates management's emphasis on recurring metrics as indicators of installed base health, positioning the business for margin tailwinds without identified major cost pressures.
Looking forward, management anticipates substantial ongoing R&D investments across product development pipelines, with expenses expected to rise, yet expresses confidence in operational cash flow to fund growth per the proven business model. Procedure growth fueling system demand and recurring strength signal durable momentum, though execution on leasing utilization and supply dynamics merits investor attention.